Posted in | News | Biosensors

QuantuMDx Ink Intellectual Property License Deal for Using Nanostructures in Biosensors

QuantuMDx Group proclaimed that it has entered into an exclusive license deal with Nanosys for various patents and patent applications covering the utilization of nanostructures in biosensors.

The intellectual property portfolio mainly covers the utilization of nanotubes and nanowires in biosensors such as field effect transistor biosensors, which were developed by Charles Lieber, who serves as a chemistry professor at Harvard.

As per the deal, QuantuMDx has received exclusive global rights for the utilization of nanomaterials for DNA sequencing and determining disease-specific nucleic acid biomarkers, while Nanosys has secured downstream royalty payments and a direct license fee. Other terms of the agreement were not revealed.

Nanosys is the owner of a wide-ranging intellectual property portfolio covering various nanotechnology features such as nanowires and quantum dots for numerous applications, with major focus on energy storage and LED backlighting. QuantuMDx Group will utilize Nanosys’ nanowire synthesis and composition technologies along with its in-house microfluidic, chemistry and biology technologies in several portable devices used for DNA sequencing and molecular diagnostics.

QuantuMDx Group’s Chief Executive Officer, Elaine Warburton stated that Nanosys’s technology enables precise diagnosis and measurement of numerous biomarkers utilizing compact arrays of biosensors that readily integrates with QuantuMDx’s DNA sequencing. The company’s medical director, Sir John Burn stated that the company is developing a user-friendly, sample-to-result instrument that can offer portable, clinical DNA sequencing. The technology is inexpensive and offers results within minutes, making it a key device in the clinical tool box, he said.

Nanosys’ Vice President of Intellectual Property and General Counsel, Andrew Filler commented that the company is introducing a number of applications of sophisticated materials to the marketplace through its continuous efforts in advancement, licensing and commercialization.

Source: http://www.quantumdx.com

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Choi, Andy. (2019, February 24). QuantuMDx Ink Intellectual Property License Deal for Using Nanostructures in Biosensors. AZoSensors. Retrieved on April 20, 2024 from https://www.azosensors.com/news.aspx?newsID=3429.

  • MLA

    Choi, Andy. "QuantuMDx Ink Intellectual Property License Deal for Using Nanostructures in Biosensors". AZoSensors. 20 April 2024. <https://www.azosensors.com/news.aspx?newsID=3429>.

  • Chicago

    Choi, Andy. "QuantuMDx Ink Intellectual Property License Deal for Using Nanostructures in Biosensors". AZoSensors. https://www.azosensors.com/news.aspx?newsID=3429. (accessed April 20, 2024).

  • Harvard

    Choi, Andy. 2019. QuantuMDx Ink Intellectual Property License Deal for Using Nanostructures in Biosensors. AZoSensors, viewed 20 April 2024, https://www.azosensors.com/news.aspx?newsID=3429.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.